We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Online Data Retrieval Software Eases Access to Cancer Cell-Line Information

By LabMedica International staff writers
Posted on 02 Aug 2012
An online application freely available to biotech and genomics researchers allows rapid data retrieval from one of the largest and best-characterized cancer cell databases.

A paper published in the July 15, 2012, issue of the journal Cancer Research described the CellMiner software application, which was designed for use with the [US] National Cancer Institute's (Bethesda, MD, USA) NCI-60 library. More...


The NCI-60 is a set of 59 human cancer cell lines derived from diverse tissues: brain, blood and bone marrow, breast, colon, kidney, lung, ovary, prostate, and skin. Since 1992 these cell lines have been subjected to a battery of experiments including; extensive pharmacological characterization by treatment with over 100,000 chemical compounds, chromosome karyotyping, and gene expression analyses conducted with various DNA microarray platforms.

CellMiner is a web application that facilitates systems biology through the retrieval and integration of the molecular and pharmacological data sets for the NCI-60 cell lines. The tools that comprise CellMiner are available online for free (please see Related Links below). These tools provide rapid access to data from 22,379 genes catalogued in the NCI-60 library and from 20,503 previously analyzed chemical compounds, including 102 [US] Food and Drug Administration (FDA)-approved drugs.

"Previously you would have to hire a bioinformatics team to sort through all of the data, but these tools put the entire database at the fingertips of any researcher," said senior author Dr. Yves Pommier, head of the laboratory of molecular pharmacology at the National Cancer Institute. "These tools allow researchers to analyze drug responses as well as make comparisons from drug to drug and gene to gene. We are looking forward to seeing how other people are going to use this tool to look at gene coregulation, regulation of gene expression, and the relationship between gene expression and cancer."

Related Links:

National Cancer Institute
CellMiner



Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Manual Pipetting Aid
Pipette Controllers macro
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.